Intravesical rad-IFNα/Syn3 for patients with high-grade, bacillus Calmette-Guérin (BCG) refractory or relapsed non-muscle invasive bladder cancer: A phase II randomized study.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Stephen A. Boorjian, Neal D. Shore, Daniel Canter, Kenneth Ogan, Lawrence Ivan Karsh, Tracy Downs, Leonard G. Gomella, Ashish M. Kamat, Yair Lotan, Robert S. Svatek, Trinity J. Bivalacqua, Robert Grubb, Tracey Krupski, Seth P. Lerner, Michael Woods, Brant Allen Inman, Matthew I. Milowsky, Nigel Parker, David Sawutz, Colin P.N. Dinney
Institutions: Mayo Clinic, Carolina Urologic Research Center, Ochsner Medical Center, Emory University, The Urology Center of Colorado, University of Wisconsin–Madison, Thomas Jefferson University, Sidney Kimmel Cancer Center, The University of Texas MD Anderson Cancer Center, The University of Texas Southwestern Medical Center, The University of Texas at San Antonio Health Science Center, Johns Hopkins University, Johns Hopkins Medicine, Washington University in St. Louis, University of Virginia, Baylor College of Medicine, University of North Carolina at Chapel Hill, Duke Medical Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4235331036